Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

In vivo imaging of cell proliferation in meningioma using 3'-deoxy-3'-[18F]fluorothymidine PET/MRI.

Bashir A, Binderup T, Vestergaard MB, Broholm H, Marner L, Ziebell M, Fugleholm K, Kjær A, Law I.

Eur J Nucl Med Mol Imaging. 2020 Feb 11. doi: 10.1007/s00259-020-04704-2. [Epub ahead of print]

PMID:
32047966
2.

P53, Somatostatin receptor 2a and Chromogranin A immunostaining as prognostic markers in high grade gastroenteropancreatic neuroendocrine neoplasms.

Nielsen K, Binderup T, Langer SW, Kjaer A, Knigge P, Grøndahl V, Melchior L, Federspiel B, Knigge U.

BMC Cancer. 2020 Jan 10;20(1):27. doi: 10.1186/s12885-019-6498-z.

3.

Imaging-assisted nanoimmunotherapy for atherosclerosis in multiple species.

Binderup T, Duivenvoorden R, Fay F, van Leent MMT, Malkus J, Baxter S, Ishino S, Zhao Y, Sanchez-Gaytan B, Teunissen AJP, Frederico YCA, Tang J, Carlucci G, Lyashchenko S, Calcagno C, Karakatsanis N, Soultanidis G, Senders ML, Robson PM, Mani V, Ramachandran S, Lobatto ME, Hutten BA, Granada JF, Reiner T, Swirski FK, Nahrendorf M, Kjaer A, Fisher EA, Fayad ZA, Pérez-Medina C, Mulder WJM.

Sci Transl Med. 2019 Aug 21;11(506). pii: eaaw7736. doi: 10.1126/scitranslmed.aaw7736.

PMID:
31434756
4.

Erratum to "Characteristics of 252 patients with bronchopulmonary neuroendocrine tumours treated at the Copenhagen NET Centre of Excellence" [Lung Cancer 132 (June) (2019) 141-149].

Grøndahl V, Binderup T, Langer SW, Petersen RH, Nielsen K, Kjaer A, Federspiel B, Knigge U.

Lung Cancer. 2019 Sep;135:235. doi: 10.1016/j.lungcan.2019.07.019. Epub 2019 Jul 31. No abstract available.

PMID:
31377004
5.

Characteristics of 252 patients with bronchopulmonary neuroendocrine tumours treated at the Copenhagen NET Centre of Excellence.

Grøndahl V, Binderup T, Langer SW, Petersen RH, Nielsen K, Kjaer A, Federspiel B, Knigge U.

Lung Cancer. 2019 Jun;132:141-149. doi: 10.1016/j.lungcan.2019.03.013. Epub 2019 Apr 5. Erratum in: Lung Cancer. 2019 Sep;135:235.

PMID:
31097087
6.

Multimodal Positron Emission Tomography Imaging to Quantify Uptake of 89Zr-Labeled Liposomes in the Atherosclerotic Vessel Wall.

Lobatto ME, Binderup T, Robson PM, Giesen LFP, Calcagno C, Witjes J, Fay F, Baxter S, Wessel CH, Eldib M, Bini J, Carlin SD, Stroes ESG, Storm G, Kjaer A, Lewis JS, Reiner T, Fayad ZA, Mulder WJM, Pérez-Medina C.

Bioconjug Chem. 2019 Jun 7. doi: 10.1021/acs.bioconjchem.9b00256. [Epub ahead of print]

PMID:
31095372
7.

Author Correction: Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates.

Lameijer M, Binderup T, van Leent MMT, Senders ML, Fay F, Malkus J, Sanchez-Gaytan BL, Teunissen AJP, Karakatsanis N, Robson P, Zhou X, Ye Y, Wojtkiewicz G, Tang J, Seijkens TTP, Kroon J, Stroes ESG, Kjaer A, Ochando J, Reiner T, Pérez-Medina C, Calcagno C, Fisher EA, Zhang B, Temel RE, Swirski FK, Nahrendorf M, Fayad ZA, Lutgens E, Mulder WJM, Duivenvoorden R.

Nat Biomed Eng. 2018 Aug;2(8):623. doi: 10.1038/s41551-018-0281-3.

PMID:
31015637
8.

Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates.

Lameijer M, Binderup T, van Leent MMT, Senders ML, Fay F, Malkus J, Sanchez-Gaytan BL, Teunissen AJP, Karakatsanis N, Robson P, Zhou X, Ye Y, Wojtkiewicz G, Tang J, Seijkens TTP, Kroon J, Stroes ESG, Kjaer A, Ochando J, Reiner T, Pérez-Medina C, Calcagno C, Fisher EA, Zhang B, Temel RE, Swirski FK, Nahrendorf M, Fayad ZA, Lutgens E, Mulder WJM, Duivenvoorden R.

Nat Biomed Eng. 2018 May;2(5):279-292. doi: 10.1038/s41551-018-0221-2. Epub 2018 Apr 16. Erratum in: Nat Biomed Eng. 2018 Aug;2(8):623.

9.

Somatostatin Analogue Treatment Primarily Induce miRNA Expression Changes and Up-Regulates Growth Inhibitory miR-7 and miR-148a in Neuroendocrine Cells.

Døssing KBV, Kjær C, Vikeså J, Binderup T, Knigge U, Culler MD, Kjær A, Federspiel B, Friis-Hansen L.

Genes (Basel). 2018 Jul 4;9(7). pii: E337. doi: 10.3390/genes9070337.

10.

PET imaging with copper-64 as a tool for real-time in vivo investigations of the necessity for cross-linking of polymeric micelles in nanomedicine.

Jensen AI, Binderup T, Ek PK, Grandjean CE, Rasmussen PH, Kjaer A, Andresen TL.

J Labelled Comp Radiopharm. 2017 Jun 30;60(8):366-374. doi: 10.1002/jlcr.3510. Epub 2017 May 30.

PMID:
28407286
11.

Prognostic Value of 18F-FLT PET in Patients with Neuroendocrine Neoplasms: A Prospective Head-to-Head Comparison with 18F-FDG PET and Ki-67 in 100 Patients.

Johnbeck CB, Knigge U, Langer SW, Loft A, Berthelsen AK, Federspiel B, Binderup T, Kjaer A.

J Nucl Med. 2016 Dec;57(12):1851-1857. Epub 2016 Jul 28.

12.

In Vivo PET Imaging of HDL in Multiple Atherosclerosis Models.

Pérez-Medina C, Binderup T, Lobatto ME, Tang J, Calcagno C, Giesen L, Wessel CH, Witjes J, Ishino S, Baxter S, Zhao Y, Ramachandran S, Eldib M, Sánchez-Gaytán BL, Robson PM, Bini J, Granada JF, Fish KM, Stroes ES, Duivenvoorden R, Tsimikas S, Lewis JS, Reiner T, Fuster V, Kjær A, Fisher EA, Fayad ZA, Mulder WJ.

JACC Cardiovasc Imaging. 2016 Aug;9(8):950-61. doi: 10.1016/j.jcmg.2016.01.020. Epub 2016 May 25.

13.

In vivo evaluation of PEGylated ⁶⁴Cu-liposomes with theranostic and radiotherapeutic potential using micro PET/CT.

Petersen AL, Henriksen JR, Binderup T, Elema DR, Rasmussen PH, Hag AM, Kjær A, Andresen TL.

Eur J Nucl Med Mol Imaging. 2016 May;43(5):941-952. doi: 10.1007/s00259-015-3272-6. Epub 2015 Dec 8.

PMID:
26646780
14.

Somatostatin-Immunoreactive Pancreaticoduodenal Neuroendocrine Neoplasms: Twenty-Three Cases Evaluated according to the WHO 2010 Classification.

Luna IE, Monrad N, Binderup T, Boisen Thoegersen C, Hilsted L, Jensen C, Federspiel B, Knigge U.

Neuroendocrinology. 2016;103(5):567-77. doi: 10.1159/000441605. Epub 2015 Oct 28.

PMID:
26505735
15.

Imaging Macrophage and Hematopoietic Progenitor Proliferation in Atherosclerosis.

Ye YX, Calcagno C, Binderup T, Courties G, Keliher EJ, Wojtkiewicz GR, Iwamoto Y, Tang J, Pérez-Medina C, Mani V, Ishino S, Johnbeck CB, Knigge U, Fayad ZA, Libby P, Weissleder R, Tawakol A, Dubey S, Belanger AP, Di Carli MF, Swirski FK, Kjaer A, Mulder WJ, Nahrendorf M.

Circ Res. 2015 Oct 23;117(10):835-45. doi: 10.1161/CIRCRESAHA.115.307024. Epub 2015 Sep 22.

16.

PET/CT Based In Vivo Evaluation of 64Cu Labelled Nanodiscs in Tumor Bearing Mice.

Huda P, Binderup T, Pedersen MC, Midtgaard SR, Elema DR, Kjær A, Jensen M, Arleth L.

PLoS One. 2015 Jul 1;10(7):e0129310. doi: 10.1371/journal.pone.0129310. eCollection 2015.

17.

64Cu-DOTATATE PET for Neuroendocrine Tumors: A Prospective Head-to-Head Comparison with 111In-DTPA-Octreotide in 112 Patients.

Pfeifer A, Knigge U, Binderup T, Mortensen J, Oturai P, Loft A, Berthelsen AK, Langer SW, Rasmussen P, Elema D, von Benzon E, Højgaard L, Kjaer A.

J Nucl Med. 2015 Jun;56(6):847-54. doi: 10.2967/jnumed.115.156539. Epub 2015 May 7.

18.

Atherosclerotic plaque targeting mechanism of long-circulating nanoparticles established by multimodal imaging.

Lobatto ME, Calcagno C, Millon A, Senders ML, Fay F, Robson PM, Ramachandran S, Binderup T, Paridaans MP, Sensarn S, Rogalla S, Gordon RE, Cardoso L, Storm G, Metselaar JM, Contag CH, Stroes ES, Fayad ZA, Mulder WJ.

ACS Nano. 2015 Feb 24;9(2):1837-47. doi: 10.1021/nn506750r. Epub 2015 Jan 28.

19.

Down-Regulation of miR-129-5p and the let-7 Family in Neuroendocrine Tumors and Metastases Leads to Up-Regulation of Their Targets Egr1, G3bp1, Hmga2 and Bach1.

Døssing KB, Binderup T, Kaczkowski B, Jacobsen A, Rossing M, Winther O, Federspiel B, Knigge U, Kjær A, Friis-Hansen L.

Genes (Basel). 2014 Dec 24;6(1):1-21. doi: 10.3390/genes6010001.

20.

A modular labeling strategy for in vivo PET and near-infrared fluorescence imaging of nanoparticle tumor targeting.

Pérez-Medina C, Abdel-Atti D, Zhang Y, Longo VA, Irwin CP, Binderup T, Ruiz-Cabello J, Fayad ZA, Lewis JS, Mulder WJ, Reiner T.

J Nucl Med. 2014 Oct;55(10):1706-11. doi: 10.2967/jnumed.114.141861. Epub 2014 Jul 24.

21.

Injectable colloidal gold in a sucrose acetate isobutyrate gelating matrix with potential use in radiation therapy.

Jølck RI, Binderup T, Hansen AE, Scherman JB, Munch af Rosenschold P, Kjaer A, Andresen TL.

Adv Healthc Mater. 2014 Oct;3(10):1680-7. doi: 10.1002/adhm.201300668. Epub 2014 Apr 15.

PMID:
24733773
22.

Positron emission tomography based analysis of long-circulating cross-linked triblock polymeric micelles in a U87MG mouse xenograft model and comparison of DOTA and CB-TE2A as chelators of copper-64.

Jensen AI, Binderup T, Kumar EK P, Kjær A, Rasmussen PH, Andresen TL.

Biomacromolecules. 2014 May 12;15(5):1625-33. doi: 10.1021/bm401871w. Epub 2014 Apr 7.

PMID:
24645913
23.

Dosimetry of 64Cu-DOTA-AE105, a PET tracer for uPAR imaging.

Persson M, El Ali HH, Binderup T, Pfeifer A, Madsen J, Rasmussen P, Kjaer A.

Nucl Med Biol. 2014 Mar;41(3):290-5. doi: 10.1016/j.nucmedbio.2013.12.007. Epub 2013 Dec 18.

24.

Positron emission tomography/computed tomography for optimized colon cancer staging and follow up.

Engelmann BE, Loft A, Kjær A, Nielsen HJ, Berthelsen AK, Binderup T, Brinch K, Brünner N, Gerds TA, Høyer-Hansen G, Kristensen MH, Kurt EY, Latocha JE, Lindblom G, Sloth C, Højgaard L.

Scand J Gastroenterol. 2014 Feb;49(2):191-201. doi: 10.3109/00365521.2013.863967. Epub 2013 Nov 29.

25.

Imaging of metastatic lymph nodes by X-ray phase-contrast micro-tomography.

Jensen TH, Bech M, Binderup T, Böttiger A, David C, Weitkamp T, Zanette I, Reznikova E, Mohr J, Rank F, Feidenhans'l R, Kjær A, Højgaard L, Pfeiffer F.

PLoS One. 2013;8(1):e54047. doi: 10.1371/journal.pone.0054047. Epub 2013 Jan 18.

26.
27.

(18)F-FDG PET imaging of murine atherosclerosis: association with gene expression of key molecular markers.

Hag AM, Pedersen SF, Christoffersen C, Binderup T, Jensen MM, Jørgensen JT, Skovgaard D, Ripa RS, Kjaer A.

PLoS One. 2012;7(11):e50908. doi: 10.1371/journal.pone.0050908. Epub 2012 Nov 30.

28.

Preoperative PET/CT in early-stage breast cancer.

Bernsdorf M, Berthelsen AK, Wielenga VT, Kroman N, Teilum D, Binderup T, Tange UB, Andersson M, Kjær A, Loft A, Graff J.

Ann Oncol. 2012 Sep;23(9):2277-2282. doi: 10.1093/annonc/mds002. Epub 2019 Dec 4.

29.

PET imaging of liposomes labeled with an [¹⁸F]-fluorocholesteryl ether probe prepared by automated radiosynthesis.

Jensen AT, Binderup T, Andresen TL, Kjær A, Rasmussen PH.

J Liposome Res. 2012 Dec;22(4):295-305. doi: 10.3109/08982104.2012.698418. Epub 2012 Jul 18.

PMID:
22803638
30.

Clinical PET of neuroendocrine tumors using 64Cu-DOTATATE: first-in-humans study.

Pfeifer A, Knigge U, Mortensen J, Oturai P, Berthelsen AK, Loft A, Binderup T, Rasmussen P, Elema D, Klausen TL, Holm S, von Benzon E, Højgaard L, Kjaer A.

J Nucl Med. 2012 Aug;53(8):1207-15. doi: 10.2967/jnumed.111.101469. Epub 2012 Jul 10.

31.

Preoperative PET/CT in early-stage breast cancer.

Bernsdorf M, Berthelsen AK, Wielenga VT, Kroman N, Teilum D, Binderup T, Tange UB, Andersson M, Kjær A, Loft A, Graff J.

Ann Oncol. 2012 Sep;23(9):2277-82. doi: 10.1093/annonc/mds002. Epub 2012 Feb 21.

32.

Positron emission tomography evaluation of somatostatin receptor targeted 64Cu-TATE-liposomes in a human neuroendocrine carcinoma mouse model.

Petersen AL, Binderup T, Jølck RI, Rasmussen P, Henriksen JR, Pfeifer AK, Kjær A, Andresen TL.

J Control Release. 2012 Jun 10;160(2):254-63. doi: 10.1016/j.jconrel.2011.12.038. Epub 2012 Jan 5.

PMID:
22245688
33.

FoxO3A promotes metabolic adaptation to hypoxia by antagonizing Myc function.

Jensen KS, Binderup T, Jensen KT, Therkelsen I, Borup R, Nilsson E, Multhaupt H, Bouchard C, Quistorff B, Kjaer A, Landberg G, Staller P.

EMBO J. 2011 Nov 16;30(22):4554-70. doi: 10.1038/emboj.2011.323.

34.

Immunolymphoscintigraphy for metastatic sentinel nodes: test of a model.

Chakera AH, Nielsen BS, Madsen J, Romer J, Kristjansen PE, Buch I, Binderup T, Ingvar C, Nalla A, Kjaer A, Hesse B.

Int J Mol Imaging. 2011;2011:828151. doi: 10.1155/2011/828151. Epub 2011 Apr 28.

35.

Evaluation of 4-[18F]fluorobenzoyl-FALGEA-NH2 as a positron emission tomography tracer for epidermal growth factor receptor mutation variant III imaging in cancer.

Denholt CL, Binderup T, Stockhausen MT, Poulsen HS, Spang-Thomsen M, Hansen PR, Gillings N, Kjær A.

Nucl Med Biol. 2011 May;38(4):509-15. doi: 10.1016/j.nucmedbio.2010.11.003. Epub 2011 Mar 1.

PMID:
21531288
36.

64Cu loaded liposomes as positron emission tomography imaging agents.

Petersen AL, Binderup T, Rasmussen P, Henriksen JR, Elema DR, Kjær A, Andresen TL.

Biomaterials. 2011 Mar;32(9):2334-41. doi: 10.1016/j.biomaterials.2010.11.059. Epub 2011 Jan 7.

PMID:
21216003
37.

Functional imaging of neuroendocrine tumors: a head-to-head comparison of somatostatin receptor scintigraphy, 123I-MIBG scintigraphy, and 18F-FDG PET.

Binderup T, Knigge U, Loft A, Mortensen J, Pfeifer A, Federspiel B, Hansen CP, Højgaard L, Kjaer A.

J Nucl Med. 2010 May;51(5):704-12. doi: 10.2967/jnumed.109.069765. Epub 2010 Apr 15.

38.

18F-fluorodeoxyglucose positron emission tomography predicts survival of patients with neuroendocrine tumors.

Binderup T, Knigge U, Loft A, Federspiel B, Kjaer A.

Clin Cancer Res. 2010 Feb 1;16(3):978-85. doi: 10.1158/1078-0432.CCR-09-1759. Epub 2010 Jan 26.

40.
41.

Quantitative gene expression of somatostatin receptors and noradrenaline transporter underlying scintigraphic results in patients with neuroendocrine tumors.

Binderup T, Knigge U, Mellon Mogensen A, Palnaes Hansen C, Kjaer A.

Neuroendocrinology. 2008;87(4):223-32. doi: 10.1159/000113128. Epub 2008 Jan 14.

PMID:
18196892
42.

Radiation exposure to surgical staff during F-18-FDG-guided cancer surgery.

Andersen PA, Chakera AH, Klausen TL, Binderup T, Grossjohann HS, Friis E, Palnaes Hansen C, Schmidt G, Kjaer A, Hesse B.

Eur J Nucl Med Mol Imaging. 2008 Mar;35(3):624-9. Epub 2007 Oct 23.

PMID:
17955240
43.

Comparative electrophysiological, functional, and histological studies of nerve lesions in rats.

Wolthers M, Moldovan M, Binderup T, Schmalbruch H, Krarup C.

Microsurgery. 2005;25(6):508-19.

PMID:
16145683

Supplemental Content

Loading ...
Support Center